AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Blisto 1MF Tablet PR

Prescription Icon
Prescription Required

Marketer

Biocon

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Blisto 1MF Tablet PR

DiabetaComb 1MF tablets are classified as antidiabetic medications, a dual-drug formulation for managing type 2 diabetes in adults. This medication helps regulate blood glucose. DiabetaComb 1MF should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as advised by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential to mitigate this risk. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with blood tests to assess blood cell counts and liver function, may be recommended by your doctor.

Primary Ingredients of Blisto 1MF Tablet PR

The provided text is "undefined," offering no content to rephrase.

Uses of Blisto 1MF Tablet PR

Managing type 2 diabetes

Major Benefits of Blisto 1MF Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Blisto 1MF Tablet PR with a meal.

Common Side effects of Blisto 1MF Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Blisto 1MF Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take Blisto 1MF Tablet PR with a meal.

How Blisto 1MF Tablet PR works:

Blisto 1MF Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Blisto 1MF Tablet PR with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Blisto 1MF Tablet PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Blisto 1MF Tablet PR are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Blisto 1MF Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician before taking this medication. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Blisto 1MF Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Blisto 1MF Tablet PR :

Should you forget a Blisto 1MF Tablet PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Blisto 1MF Tablet PR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Blisto 1MF Tablet PR

Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Prevent access by children, pets, and others.
Lactic acidosis, a serious medical condition resulting from excessive blood lactic acid, is a potential adverse effect of Blisto 1MF Tablet PR. Also termed Metformin-associated lactic acidosis (MALA), this rare complication poses a significant risk to individuals with pre-existing kidney impairment, the elderly, and those who consume substantial alcohol. Characteristic symptoms encompass muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms manifest, discontinue Blisto 1MF Tablet PR use and seek immediate medical attention.
Blisto 1MF Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood sugar control when coupled with a healthy diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for managing type 1 DM.
Blisto 1MF Tablet PR administration may result in frequently reported adverse events including hypoglycemia, taste disturbances, nausea, abdominal discomfort, diarrhea, and cephalalgia. Rare but potentially severe reactions such as lactic acidosis are also possible. Prolonged therapy may additionally cause Vitamin B12 deficiency.
Prolonged Blisto 1MF Tablet PR administration can indeed lead to vitamin B12 deficiency. This medication impairs the stomach's absorption of vitamin B12. Untreated deficiency may manifest as anemia, neurological issues including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 is recommended by some investigators at least annually.
Indeed, Blisto 1MF Tablet PR administration may lead to hypoglycemia, characterized by low blood glucose. Manifestations of this condition encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. It's advisable to always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Consuming alcohol while taking Blisto 1MF Tablet PR is unsafe due to the risk of decreased blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Blisto 1MF Tablet PR
90
MRP 110
18% off